Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
HORIZON PHARMA, INC.
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
2010
Item 2 Issuer Principal Place of Business and Contact Information
520 LAKE COOK ROAD
SUITE 520
DEERFIELD, IL 60015
Phone Number:
subscription required
Item 3. Related Persons
Name
TIMOTHY P. WALBERT
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
ROBERT DE VAERE
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
LOUIS C. BOCK
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JEFF HIMAWAN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JEFFREY W. BIRD
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
RONALD PAULI
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JEAN-FRANCOIS FORMELA
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MICHAEL GREY
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
GINO SANTINI
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
02/22/2012
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
- Option, Warrant or Other Right to Acquire Another Security
- Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 12. Sales Compensation
Recipient
JMP SECURITIES, LLC
Recipient CRD Number
22208
(Associated) Broker or Dealer)
JMP SECURITIES, LLC
(Associated) Broker or Dealer CRD Number
22208
Address
600 MONTGOMERY STREET
SUITE 1100
SAN FRANCISCO, CA 94111
States of Solicitation
Item 12. Sales Compensation
Recipient
COWEN COMPANY LLC
Recipient CRD Number
7616
(Associated) Broker or Dealer)
COWEN COMPANY LLC
(Associated) Broker or Dealer CRD Number
7616
Address
599 LEXINGTON AVENUE
20TH FLOOR
NEW YORK, NY 10022
States of Solicitation
Item 12. Sales Compensation
Recipient
STIFEL, NICOLAUS COMPANY INCORPORATED
Recipient CRD Number
793
(Associated) Broker or Dealer)
STIFEL, NICOLAUS COMPANY INCORPORATED
(Associated) Broker or Dealer CRD Number
793
Address
ONE MONTGOMERY STREET
SUITE 3700
SAN FRANCISCO, CA 94104
States of Solicitation
Item 13. Offering and Sales Amounts
Total Offering Amount
32772
Total Amount Sold
32772
Total Remaining to be Sold
0
Clarification of Response
INCLUDES AMOUNTS RECEIVABLE BY THE COMPANY UPON THE EXERCISE OF WARRANTS (ASSUMING NO NET-ISSUE EXERCISE). THE WARRANTS WERE ISSUED AS CONSIDERATION FOR PROVIDING LOAN CAPITAL.
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
6
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
3000000.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
HORIZON PHARMA, INC.
Issuer Signature
/S/ ROBERT J. DE VAERE
Signer Name
ROBERT J. DE VAERE
Signer Title
EXECUTIVE VICE PRESIDENT AND CFO
Signature Date
03/07/2012
